{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T09:13:57Z","timestamp":1788340437629,"version":"build-2803163510"},"reference-count":154,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Fungi","JoF"],"abstract":"<jats:p>Globally, invasive fungal diseases are increasing in incidence and are associated with high rates of mortality. A lack of effective diagnostic protocols, antifungal resistance and poor antifungal stewardship contribute to negative outcomes. Aspergillus, Candida, Cryptococcus, and Pneumocystis are the most common pathogens associated with fatal fungal diseases. These species are responsible for 90% of reported invasive fungal deaths globally. Fungal species employ a diverse and effective array of virulence factors to sabotage, evade, and manipulate host immune systems, allowing for colonisation and dissemination in vivo. Invasive fungal infections are clinically challenging, as they penetrate organs and deep tissues, contributing to the aetiology of respiratory tract, endocarditis, meningitis, and medical device infections and resulting in false negative diagnostic attempts. The 2025 WHO report outlines a lack of diagnostic and therapeutic options available, especially in low-to-middle-income countries. Geographical and economic factors impact fungal disease and mortality rates. There is an urgent need for new approaches to combat fungal diseases clinically with improved biocompatibility profiles. This timely review discusses the prevalent invasive fungal species, namely, Candida, Aspergillus, Cryptococcus, and Pneumocystis, which have high mortality rates, as identified by the WHO priority pathogen list, and discusses recent advances in the treatment of fungal diseases. This dissemination of information is an important aspect of the United Nations Sustainable Development Goals (SDGs) and One Health.<\/jats:p>","DOI":"10.3390\/jof12090659","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T07:53:11Z","timestamp":1788335591000},"page":"659","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Review of the Therapeutic Challenges and Novel Treatment Options in Mitigating Invasive Mycosis Associated with Aspergillus, Candida, Cryptococcus, and Pneumocystis"],"prefix":"10.3390","volume":"12","author":[{"given":"Elaine","family":"Meade","sequence":"first","affiliation":[{"name":"Department of Life Science and Pharmacy, Atlantic Technological University, Ash Lane, F91 YW50 Sligo, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Slattery","sequence":"additional","affiliation":[{"name":"Mark Anthony Slattery, Veterinary Surgeon, F92 E619 Sligo, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1240-5315","authenticated-orcid":false,"given":"Mary","family":"Garvey","sequence":"additional","affiliation":[{"name":"Department of Life Science and Pharmacy, Atlantic Technological University, Ash Lane, F91 YW50 Sligo, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.3390\/encyclopedia2040118","article-title":"Antifungals and Drug Resistance","volume":"2","author":"Hossain","year":"2022","journal-title":"Encyclopedia"},{"key":"ref_2","unstructured":"(2026, July 23). Available online: https:\/\/www.cdc.gov\/fungal\/data-research\/facts-stats\/by-the-numbers.html."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e428","DOI":"10.1016\/S1473-3099(23)00692-8","article-title":"Global incidence and mortality of severe fungal disease","volume":"24","author":"Denning","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"ref_4","unstructured":"(2026, July 23). Available online: https:\/\/gaffi.org\/why\/fungal-disease-frequency\/."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41586-024-08419-4","article-title":"Fungal impacts on Earth\u2019s ecosystems","volume":"638","author":"Case","year":"2025","journal-title":"Nature"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Thambugala, K.M., Daranagama, D.A., Tennakoon, D.S., Jayatunga, D.P.W., Hongsanan, S., and Xie, N. (2024). Humans vs. Fungi: An Overview of Fungal Pathogens against Humans. Pathogens, 13.","DOI":"10.3390\/pathogens13050426"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss7107a1","article-title":"Surveillance for Coccidioidomycosis, Histoplasmosis, and Blastomycosis\u2014United States, 2019","volume":"71","author":"Smith","year":"2022","journal-title":"MMWR Surveill. Summ."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Li, D., Fan, S., Zhao, H., Song, J., Guo, L., Li, W., Xu, X., and Li, Q. (2025). Worldwide trends and future projections of fungal skin disease burden: A comprehensive analysis from the Global Burden of Diseases study 2021. Front. Public Health, 13.","DOI":"10.3389\/fpubh.2025.1580221"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Garvey, M., and Rowan, N.J. (2023). Pathogenic Drug Resistant Fungi: A Review of Mitigation Strategies. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24021584"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2400803","DOI":"10.1183\/13993003.00803-2024","article-title":"Fungal lung disease","volume":"64","author":"Jaggi","year":"2024","journal-title":"Eur. Respir. J."},{"key":"ref_11","unstructured":"European Centre for Disease Prevention and Control (2025). Survey on the Epidemiological Situation, Laboratory Capacity and Preparedness for Candidozyma (Candida) Auris, 2024, ECDC."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"De Gaetano, S., Midiri, A., Mancuso, G., Avola, M.G., and Biondo, C. (2024). Candida auris Outbreaks: Current Status and Future Perspectives. Microorganisms, 12.","DOI":"10.3390\/microorganisms12050927"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11046-025-00965-3","article-title":"Epidemiology, Risk Factors and Mortality of Fungal Bloodstream Infection: 14 Years of Experience at a Teaching Hospital","volume":"190","year":"2025","journal-title":"Mycopathologia"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e005961","DOI":"10.1136\/rmdopen-2025-005961","article-title":"Invasive fungal infections in patients with rheumatoid arthritis: An explorative analysis from the German RABBIT register","volume":"11","author":"Purschke","year":"2025","journal-title":"RMD Open"},{"key":"ref_15","first-page":"20499361251313841","article-title":"The impact of climate change on the epidemiology of fungal infections: Implications for diagnosis, treatment, and public health strategies","volume":"12","author":"George","year":"2025","journal-title":"Ther. Adv. Infect. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1007\/s12088-023-01174-6","article-title":"Prevalence and comparison of superficial-cutaneous fungal infections before and during the COVID-19 pandemic in shiraz, Iran: A retrospective study (2018\u20132021)","volume":"64","author":"Jabrodini","year":"2024","journal-title":"Indian J. Microbiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1099\/jmm.0.002128","article-title":"Cryptococcus neoformans responds to presence of Mycobacterium by diversifying its morphologies and remodelling its capsular material","volume":"75","author":"Ross","year":"2026","journal-title":"J. Med. Microbiol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Atiencia-Carrera, M.B., Cabezas-Mera, F.S., Tejera, E., and Machado, A. (2022). Prevalence of biofilms in Candida spp. Bloodstream Infections: A Meta-Analysis. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0263522"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1001\/jamadermatol.2025.6135","article-title":"Measuring Progress of 2030 Skin-Related Neglected Tropical Diseases Sustainable Development Goals","volume":"162","author":"Cao","year":"2026","journal-title":"JAMA Dermatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"106882","DOI":"10.1016\/j.rmed.2022.106882","article-title":"Autopsy study of fatal invasive pulmonary aspergillosis: Often undiagnosed premortem","volume":"199","author":"Mudrakola","year":"2022","journal-title":"Respir. Med."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Maertens, J.A. (2024). Invasive Fungal Diseases. The EBMT Handbook: Hematopoietic Cell Transplantation and Cellular Therapies, Springer. [8th ed.]. Chapter 37.","DOI":"10.1007\/978-3-031-44080-9_37"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1080\/23744235.2026.2701175","article-title":"Beyond the Blueprint: Why WHO\u2019s new fungal disease framework must become a national health system priority","volume":"58","author":"Khalif","year":"2026","journal-title":"Infect. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"348","DOI":"10.3390\/idr13020034","article-title":"Investigation of Alternative Therapeutic and Biocidal Options to Combat Antifungal-Resistant Zoonotic Fungal Pathogens Isolated from Companion Animals","volume":"13","author":"Meade","year":"2021","journal-title":"Infect. Dis. Rep."},{"key":"ref_24","first-page":"20499361231161387","article-title":"Flucytosine and its clinical usage","volume":"10","author":"Sigera","year":"2023","journal-title":"Ther. Adv. Infect. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S2666-5247(24)00042-9","article-title":"The WHO fungal priority pathogens list: A crucial reappraisal to review the prioritisation","volume":"5","author":"Casalini","year":"2024","journal-title":"Lancet Microbe"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"5352","DOI":"10.1038\/s41467-022-32249-5","article-title":"The importance of antimicrobial resistance in medical mycology","volume":"13","author":"Gow","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"101307","DOI":"10.1016\/j.lanmic.2025.101307","article-title":"Global perspective on gaps in fungal diagnostics in low-resource settings: WHO landscape analysis and research priorities for invasive fungal diseases","volume":"7","author":"Murtagh","year":"2026","journal-title":"Lancet Microbe"},{"key":"ref_28","unstructured":"(2026, June 20). Available online: https:\/\/www.who.int\/news\/item\/01-04-2025-who-issues-its-first-ever-reports-on-tests-and-treatments-for-fungal-infections."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Meade, E., Slattery, M.A., and Garvey, M. (2024). Antimicrobial Resistance Profile of Zoonotic Clinically Relevant WHO Priority Pathogens. Pathogens, 13.","DOI":"10.3390\/pathogens13111006"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"5407","DOI":"10.1038\/s41467-026-71762-9","article-title":"The dual role of azoles: Lifesaving antifungals and drivers of resistance\u2014A One Health perspective","volume":"17","author":"Roohi","year":"2026","journal-title":"Nat. Commun."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s00134-025-07797-1","article-title":"Invasive fungal infections in patients with liver disease: Immunological and clinical considerations for the intensive care unit","volume":"51","author":"Epelbaum","year":"2025","journal-title":"Intensive Care Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s13054-019-2497-3","article-title":"Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: Results of the EUCANDICU project","volume":"23","author":"Bassetti","year":"2019","journal-title":"Crit. Care"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3324\/haematol.2016.152900","article-title":"ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients","volume":"102","author":"Tissot","year":"2017","journal-title":"Haematologica"},{"key":"ref_34","first-page":"29","article-title":"In vitro sensitivity of Candida albicans isolates to antifungal agents and the effect of biofilms on the drug resistance rate","volume":"18","author":"Madar","year":"2024","journal-title":"Sana\u2019a Univ. J. Med. Health Sci."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.mmcr.2018.08.005","article-title":"Successful treatment of C. auris shunt infection with intraventricular caspofungin","volume":"22","author":"Singhal","year":"2018","journal-title":"Med. Mycol. Case Rep."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e02311","DOI":"10.1016\/j.idcr.2025.e02311","article-title":"An unusual clinical presentation of cryptococcal meningitis: The importance of a detailed history and physical","volume":"41","author":"Nakahira","year":"2025","journal-title":"IDCases"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12987-025-00644-x","article-title":"Hyphal penetration is the major pathway of translocation of Candida albicans across the blood-cerebrospinal fluid barrier","volume":"22","author":"Schmidt","year":"2025","journal-title":"Fluids Barriers CNS"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S1473-3099(22)00234-1","article-title":"Outcomes of flucytosine-containing combination treatment for cryptococcal meningitis in a South African national access programme: A cross-sectional observational study","volume":"22","author":"Mashau","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Khan, M.A., Khan, A., Azam, M., Iqubal, M.Z., and Younus, H. (2026). Liposomal Methylglyoxal Targets Virulence and Intracellular Persistence to Overcome Amphotericin B Resistance in Cryptococcus neoformans. Int. J. Mol. Sci., 27.","DOI":"10.3390\/ijms27114773"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Wang, Y., Cui, X., Tian, R., and Wang, P. (2024). The epidemiological characteristics of invasive pulmonary aspergillosis and risk factors for treatment failure: A retrospective study. BMC Pulm. Med., 24.","DOI":"10.1186\/s12890-024-03381-3"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e43862","DOI":"10.1097\/MD.0000000000043862","article-title":"The treatment of amphotericin B-resistant C neoformans meningitis: A case report and literature review","volume":"104","author":"Long","year":"2025","journal-title":"Medicine"},{"key":"ref_42","first-page":"430","article-title":"Diagnosing invasive pulmonary aspergillosis in ICU patients: Putting the puzzle together","volume":"25","author":"Blot","year":"2019","journal-title":"Curr. Opin. Crit. Care"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e0077823","DOI":"10.1128\/aac.00778-23","article-title":"Oteseconazole versus fluconazole for the treatment of severe vulvovaginal candidiasis: A multicenter, randomized, double-blinded, phase 3 trial","volume":"68","author":"Wang","year":"2024","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1186\/s13054-018-2221-8","article-title":"Clinical course, treatment and outcome of Pneumocystis pneumonia in immunocompromised adults: A retrospective analysis over 17 years","volume":"22","author":"Schmidt","year":"2018","journal-title":"Crit. Care"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Lee, J.E., Kang, D.H., and Ju, H. (2025). Epidemiology and risk factors of fungal pathogens in sepsis: A prospective nationwide multicenter cohort study. BMC Infect. Dis., 25.","DOI":"10.1186\/s12879-025-10722-y"},{"key":"ref_46","first-page":"A111","article-title":"P29\u2005Pneumocystis jirovecii pneumonia\u2014Clinical features and predisposing factors from a single large centre","volume":"73","author":"Jafri","year":"2018","journal-title":"Thorax"},{"key":"ref_47","unstructured":"(2026, July 30). Available online: https:\/\/clinicalinfo.hiv.gov\/en\/guidelines\/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections\/pneumocystis."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1159\/000548096","article-title":"Severe Pneumocystis jirovecii Pneumonia That Was Difficult to Diagnose due to Complications of Postoperative Candida Sepsis in an Elderly Patient with Ulcerative Colitis: A Case Report","volume":"19","author":"Toritani","year":"2025","journal-title":"Case Rep. Gastroenterol."},{"key":"ref_49","first-page":"135","article-title":"Pneumocystis Jirovecii Pneumonia in Patients Without HIV: A UK 5-Year Retrospective Study","volume":"13","author":"Ebere","year":"2025","journal-title":"EMJ Respir."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e0036124","DOI":"10.1128\/jcm.00361-24","article-title":"An overview of the laboratory diagnosis of Pneumocystis jirovecii pneumonia","volume":"63","author":"Cartagena","year":"2025","journal-title":"J. Clin. Microbiol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1007\/s00134-024-07489-2","article-title":"Pneumocystis pneumonia in intensive care: Clinical spectrum, prophylaxis patterns, antibiotic treatment delay impact, and role of corticosteroids. A French multicentre prospective cohort study","volume":"50","author":"Kamel","year":"2024","journal-title":"Intensive Care Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e0327723","DOI":"10.1128\/mbio.03277-23","article-title":"Slicing through the challenge of maintaining Pneumocystis in the laboratory","volume":"15","author":"Nev","year":"2024","journal-title":"mBio"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Mirza, S.N., Carella, A., and Thompson, J.W. (2026). Enzymatic glycosylation and amidation reshapes polyene bioactivity. Nature.","DOI":"10.1038\/s41586-026-10834-8"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Garcia-Sherman, M.C., Hamid, S.A., Jackson, D.N., Thomas, J., and Lipke, P.N. (2025). Functional Amyloids in Adhesion of Non-albicans Candida Species. Pathogens, 14.","DOI":"10.3390\/pathogens14080723"},{"key":"ref_55","unstructured":"(2026, July 30). Available online: https:\/\/www.ema.europa.eu\/en\/search?keywords=allwords&search_api_fulltext=caspofungin&f%5B0%5D=ema_search_entity_is_document%3ADocument."},{"key":"ref_56","unstructured":"(2026, July 30). Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/sepsis."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"566","DOI":"10.15698\/mic2018.12.662","article-title":"Insights into the host-pathogen interaction: C. albicans manipulation of macrophage pyroptosis","volume":"5","author":"Cowen","year":"2018","journal-title":"Microb. Cell"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Kaur, G., Chawla, S., Kumar, P., and Singh, R. (2023). Advancing Vaccine Strategies against Candida Infections: Exploring New Frontiers. Vaccines, 11.","DOI":"10.3390\/vaccines11111658"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1556\/1886.2019.00011","article-title":"Immune response in bacterial and Candida sepsis","volume":"9","author":"Patricio","year":"2019","journal-title":"Eur. J. Microbiol. Immunol."},{"key":"ref_60","first-page":"253","article-title":"Sepsis Pathophysiology, Chronic Critical Illness, and Persistent Inflammation-Immunosuppression and Catabolism Syndrome","volume":"45","author":"Brakenridge","year":"2016","journal-title":"Crit. Care Med."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Garvey, M. (2024). Hospital Acquired Sepsis, Disease Prevalence, and Recent Advances in Sepsis Mitigation. Pathogens, 13.","DOI":"10.3390\/pathogens13060461"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"e71064","DOI":"10.1002\/hsr2.71064","article-title":"Characteristics and In-Hospital Outcomes of Patients With Septic Shock in the Adult Medical Intensive Care Unit of a Tertiary Hospital in Ethiopia: A Prospective Observational Study","volume":"8","author":"Zeleke","year":"2025","journal-title":"Health Sci. Rep."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jinf.2023.05.005","article-title":"Breakthrough invasive fungal infection among patients with haematologic malignancies: A national, prospective, and multicentre study","volume":"87","author":"Ramos","year":"2023","journal-title":"J. Infect."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"e1063","DOI":"10.1097\/CCM.0000000000005337","article-title":"Surviving sepsis campaign: International guidelines for management of sepsis and septic shock 2021","volume":"49","author":"Evans","year":"2021","journal-title":"Crit. Care Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"100708","DOI":"10.1016\/j.mmcr.2025.100708","article-title":"Fungal sepsis in a 7-month-old female: Diagnosis through peripheral blood smear","volume":"48","author":"Bedaso","year":"2025","journal-title":"Med. Mycol. Case Rep."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Shatrit, H., Deeb, S., Tamimi, M., Smerat, M.I., and Alzatari, I. (2025). Challenging neonatal central nervous system fungal infection diagnosed by MRI: A case report. Front. Pediatr., 13.","DOI":"10.3389\/fped.2025.1691551"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"238","DOI":"10.4266\/acc.2023.00437","article-title":"Septic shock due to invasive pulmonary aspergillosis without conventional risk factors","volume":"38","author":"Shin","year":"2023","journal-title":"Acute Crit. Care"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"A1842","DOI":"10.1016\/j.chest.2024.06.1156","article-title":"Disseminated cryptococcal infection and septic shock in a non-HIV patient on chronic steroid therapy","volume":"166","author":"Simonetti","year":"2024","journal-title":"Chest"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.mmcr.2019.10.003","article-title":"First Case Report of Fulminant Septic Shock From Meningococcemia Associated With Cryptococcus neoformans Coinfection in an Immunocompetent Patient","volume":"26","author":"Dienstmann","year":"2019","journal-title":"Med. Mycol. Case Rep."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"15059","DOI":"10.1038\/s41598-022-19405-z","article-title":"Clinical and microbiological characteristics of and risk factors for bloodstream infections among patients with extracorporeal membrane oxygenation: A single-center retrospective cohort study","volume":"12","author":"Lee","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"e280","DOI":"10.1016\/S1473-3099(24)00749-7","article-title":"Global guideline for the diagnosis and management of candidiasis: An initiative of the ECMM in cooperation with ISHAM and ASM","volume":"25","author":"Cornely","year":"2025","journal-title":"Lancet Infect. Dis."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Parslow, B.Y., and Thornton, C.R. (2022). Continuing Shifts in Epidemiology and Antifungal Susceptibility Highlight the Need for Improved Disease Management of Invasive Candidiasis. Microorganisms, 10.","DOI":"10.3390\/microorganisms10061208"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Ferreira-Gomes, M., Wich, M., B\u00f6de, S., Hube, B., Jacobsen, I.D., and Jungnickel, B. (2021). B Cell Recognition of Candida albicans Hyphae via TLR 2 Promotes IgG1 and IL-6 Secretion for TH17 Differentiation. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.698849"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1038\/s41467-022-31237-z","article-title":"Trans-cellular tunnels induced by the fungal pathogen Candida albicans facilitate invasion through successive epithelial cells without host damage","volume":"13","author":"Lachat","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"e00434-22","DOI":"10.1128\/iai.00434-22","article-title":"Fungal mechanisms of intracellular survival: What can we learn from bacterial pathogens?","volume":"91","author":"Stuckey","year":"2023","journal-title":"Infect. Immun."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"101738","DOI":"10.1016\/j.smim.2023.101738","article-title":"\u201cUnder Pressure\u201d\u2014How fungi evade, exploit, and modulate cells of the innate immune system","volume":"66","author":"Lange","year":"2023","journal-title":"Semin. Immunol."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"de Castro, P.A., Colabardini, A.C., Moraes, M., Horta, M.A.C., Knowles, S.L., and Raja, H.A. (2022). Regulation of gliotoxin biosynthesis and protection in Aspergillus species. PLoS Genet., 18.","DOI":"10.1371\/journal.pgen.1009965"},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Cano-P\u00e9rez, M., Caballero P\u00e9rez, J.d.D., G\u00f3mez Garc\u00eda de la Pedrosa, E., and G\u00f3mez-L\u00f3pez, A. (2026). Biofilm Formation in Aspergillus fumigatus: A Comparative Study of Strains from Different Origins. Microorganisms, 14.","DOI":"10.3390\/microorganisms14020272"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"e70169","DOI":"10.1111\/myc.70169","article-title":"Biocide Response of Candida auris","volume":"69","author":"Erganis","year":"2026","journal-title":"Mycoses"},{"key":"ref_80","unstructured":"(2026, July 28). Available online: https:\/\/www.cdc.gov\/candida-auris\/hcp\/laboratories\/identification-of-c-auris.html."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1139\/facets-2021-0157","article-title":"Peptidases: Promising antifungal targets of the human fungal pathogen, Cryptococcus neoformans","volume":"7","year":"2022","journal-title":"Facets"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Padr\u00f3-Villegas, L., and Mora-Montes, H.M. (2026). Heat Shock Proteins in Medically Relevant Fungal Pathogens: From Molecular Chaperones to Virulence Factors and Therapeutic Targets. J. Fungi, 12.","DOI":"10.3390\/jof12060414"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"ftae003","DOI":"10.1093\/femspd\/ftae003","article-title":"Macrophage pyroptosis induced by Candida albicans","volume":"82","author":"Zhang","year":"2024","journal-title":"Pathog. Dis."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"e01409-24","DOI":"10.1128\/mbio.01409-24","article-title":"Pneumocystis murina Promotes Inflammasome Formation and NETosis during Pneumocystis Pneumonia","volume":"15","author":"Sayson","year":"2024","journal-title":"mBio"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"e00301-22","DOI":"10.1128\/mbio.00301-22","article-title":"Extracellular Vesicles Regulate Biofilm Formation and Yeast-to-Hypha Differentiation in Candida albicans","volume":"13","author":"Honorato","year":"2022","journal-title":"mBio"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"uqac015","DOI":"10.1093\/femsml\/uqac015","article-title":"Cryptococcus neoformans releases proteins during intracellular residence that affect the outcome of the fungal-macrophage interaction","volume":"3","author":"Jung","year":"2022","journal-title":"Microlife"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"109139","DOI":"10.1016\/j.celrep.2021.109139","article-title":"\u03b2-Glucan-stimulated neutrophil secretion of IL-1\u03b1 is independent of GSDMD and mediated through extracellular vesicles","volume":"35","author":"Ratitong","year":"2021","journal-title":"Cell Rep."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Kwaku, G.N., Jensen, K.N., Simaku, P., Floyd, D.J., Saelens, J.W., Reardon, C.M., Ward, R.A., Basham, K.J., Hepworth, O.W., and Vyas, T.D. (2025). Extracellular vesicles from diverse fungal pathogens induce species-specific and endocytosis-dependent immunomodulation. PLoS Pathog., 21.","DOI":"10.1101\/2025.01.03.631181"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Piraine, E.A., Oliveira, H.T., Santos, P.W., Froldi, J.L., Oliveira, T.M.B., Rezende, C.P., Trentin, G.E.S., Nogueira, L.F.B., Colombo, A.L., and Casadevall, A. (2025). Cross-Species Communication via Fungal Extracellular Vesicles. bioRxiv.","DOI":"10.1101\/2025.02.03.636213"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s11274-026-04923-z","article-title":"Exploring the roles of fungal extracellular vesicles in fungal pathogenesis and symbiosis: Current understandings and future perspectives","volume":"42","author":"Sarkar","year":"2026","journal-title":"World J. Microbiol. Biotechnol."},{"key":"ref_91","first-page":"e00822-21","article-title":"Comparative Molecular and Immunoregulatory Analysis of Extracellular Vesicles from Candida albicans and Candida auris","volume":"6","author":"Heyman","year":"2021","journal-title":"mSystems"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"e02303-24","DOI":"10.1128\/mbio.02303-24","article-title":"Breaking down biofilms across critical priority fungal pathogens: Proteomics and computational innovation for mechanistic insights and new target discovery","volume":"16","author":"Romero","year":"2025","journal-title":"mBio"},{"key":"ref_93","unstructured":"Botha, D., Truter, C., Bester, E., and Wolfaardt, G. (2025). Multifaceted and Real-Time Biofilm Characterisation of Model and Non-Model Yeast Strains, Federation of European Microbiological Societies Annual Congress & Exhibition (FEMS Micro)."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"123351","DOI":"10.1016\/j.wneu.2024.10.080","article-title":"Brainstem cryptococcoma","volume":"195","author":"Lan","year":"2025","journal-title":"World Neurosurg."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Puerner, C., Morelli, K.A., Kerkaert, J.D., Jones, J.T., Quinn, K.G., Vellanki, S., and Cramer, R.A. (2025). Transcriptional analysis of developing Aspergillus fumigatus biofilms reveals metabolic shifts required for biofilm maintenance. bioRxiv.","DOI":"10.1101\/2025.06.02.657448"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"5963","DOI":"10.1038\/s41598-026-36278-8","article-title":"Overcoming Candida albicans biofilm drug resistance via azole-sophorolipid synergy","volume":"16","author":"Jayasekara","year":"2026","journal-title":"Sci. Rep."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s42770-026-01933-9","article-title":"Neonatal Candida infections in Brazil: Study on virulence and antifungal susceptibility with predominance of non-albicans Candida","volume":"57","author":"Martins","year":"2026","journal-title":"Braz. J. Microbiol."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Chhoker, K., Hausner, G., and Harris, S.D. (2025). Regulation of melanin production in fungi. Front. Fungal Biol., 6.","DOI":"10.3389\/ffunb.2025.1621764"},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Souza, J.A.M., Gurgel, I.L.S., Malacco, N.L.S.O., Martins, F.R.B., Queiroz-Junior, C.M., Teixeira, M.M., and Soriani, F.M. (2022). Pre-Exposure With Extracellular Vesicles From Aspergillus fumigatus Attenuates Inflammatory Response and Enhances Fungal Clearance in a Murine Model Pulmonary Aspergillosis. Front. Cell. Infect. Microbiol., 12.","DOI":"10.3389\/fcimb.2022.898619"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"e70138","DOI":"10.1111\/cbdd.70138","article-title":"Identification and evaluation of besifloxacin as repurposed antifungal drug in combination with fluconazole against candida albicans","volume":"105","author":"Chakraborty","year":"2025","journal-title":"Chem. Biol. Drug Des."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Su, S., Shi, X., Xu, W., Li, Y., Chen, X., and Jia, S. (2020). Antifungal activity and potential mechanism of panobinostat in combination with fluconazole against candida albicans. Front. Microbiol., 11.","DOI":"10.3389\/fmicb.2020.01584"},{"key":"ref_102","first-page":"e73405","article-title":"Repositioning 2-Mercaptobenzothiazole and Sulfonamides as Antifungals Against Multidrug-Resistant Candida albicans: In Vitro and In Silico Insights","volume":"19","year":"2026","journal-title":"ChemistrySelect"},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Li, W., Feng, Y., Feng, Z., Wang, L., Whiteway, M., Lu, H., and Jiang, Y. (2024). Pitavastatin Calcium Confers Fungicidal Properties to Fluconazole by Inhibiting Ubiquinone Biosynthesis and Generating Reactive Oxygen Species. Antioxidants, 13.","DOI":"10.3390\/antiox13060667"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"myae083","DOI":"10.1093\/mmy\/myae083","article-title":"A global perspective of the changing epidemiology of invasive fungal disease and real-world experience with the use of isavuconazole","volume":"62","author":"Thompson","year":"2024","journal-title":"Med. Mycol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"109132","DOI":"10.1016\/j.bioorg.2025.109132","article-title":"Design, synthesis, and activity evaluation of novel tetrazole-based CYP51 inhibitors","volume":"166","author":"Zhang","year":"2025","journal-title":"Bioorg Chem."},{"key":"ref_106","unstructured":"(2026, July 30). WHO Report 2025. Available online: https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/491233fa-c87e-4447-b84f-708c001fc85b\/content."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"454","DOI":"10.3390\/idr15040046","article-title":"Antimicrobial Peptides Demonstrate Activity against Resistant Bacterial Pathogens","volume":"15","author":"Garvey","year":"2023","journal-title":"Infect. Dis. Rep."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1038\/s41564-024-01662-5","article-title":"A dual-targeting antifungal is effective against multidrug-resistant human fungal pathogens","volume":"9","author":"Zhou","year":"2024","journal-title":"Nat. Microbiol."},{"key":"ref_109","first-page":"100399","article-title":"A cell wall-targeting urease-derived peptide as a potential antifungal agent against Candida species","volume":"8","author":"Perin","year":"2025","journal-title":"Curr. Res. Microb. Sci."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"e09567","DOI":"10.1002\/advs.202509567","article-title":"Repositioning Antimicrobial Peptides Against WHO-Priority Fungi","volume":"12","year":"2025","journal-title":"Adv. Sci."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"107562","DOI":"10.1016\/j.micpath.2025.107562","article-title":"Isolation and Characterization of a Phage Against the Multidrug-Resistant Candida albicans ATCC 10231 Strain From Raw Sewage","volume":"204","author":"Hasan","year":"2025","journal-title":"Microb. Pathog."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"18786","DOI":"10.1038\/s41598-025-04026-z","article-title":"A virus based vaccine combined with IL12 gene therapy eradicates aggressive melanoma","volume":"15","author":"Brezar","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"108251","DOI":"10.1016\/j.jip.2024.108251","article-title":"A mycoviral infection drives virulence and ecological fitness of the entomopathogenic fungus Beauveria bassiana","volume":"209","year":"2025","journal-title":"J. Invertebr. Pathol."},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Garvey, M. (2026). Bacteriophages as Antibacterial Agents Against Bovine Pathobionts Associated with Foodborne Human Morbidity. Viruses, 18.","DOI":"10.3390\/v18030392"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"106729","DOI":"10.1016\/j.micpath.2024.106729","article-title":"Bioinspired ferromagnetic NiFe2O4 nanoparticles: Eradication of fungal and drug-resistant bacterial pathogens and their established biofilm","volume":"193","author":"Ansari","year":"2024","journal-title":"Microb. Pathog."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"123663","DOI":"10.1016\/j.ijpharm.2023.123663","article-title":"Targeted DPPC\/DMPG surface-modified voriconazole lipid nanoparticles control invasive pulmonary aspergillosis in immunocompromised population: In-vitro and in-vivo assessment","volume":"649","author":"Fayyaz","year":"2024","journal-title":"Int. J. Pharm."},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"El-Gazzar, N., Elez, R.M.M.A., Attia, A.S.A., Abdel-Warith, A.W.A., Darwish, M.M., Younis, E.M., Eltahlawi, R.A., Mohamed, K.I., Davies, S.J., and Elsohaby, I. (2024). Antifungal and antibiofilm effects of probiotic Lactobacillus salivarius, zinc nanoparticles, and zinc nanocomposites against Candida albicans from Nile tilapia (Oreochromis niloticus), water and humans. Front. Cell. Infect. Microbiol., 14.","DOI":"10.3389\/fcimb.2024.1358270"},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Yassin, M.T., Mostafa, A.A.-F., Al-Askar, A.A., and Al-Otibi, F.O. (2022). Synergistic Antifungal Efficiency of Biogenic Silver Nanoparticles with Itraconazole against Multidrug-Resistant Candidal Strains. Crystals, 12.","DOI":"10.3390\/cryst12060816"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.2147\/IJN.S511099","article-title":"Lung-Targeted Itraconazole Delivery Using PVA-Based Nano-in-Microparticles for Improved Treatment of Pulmonary Aspergillosis","volume":"20","author":"Jeong","year":"2025","journal-title":"Int. J. Nanomed."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"124938","DOI":"10.1016\/j.ijpharm.2024.124938","article-title":"Posaconazole nanocrystals dry powder inhalers for the local treatment of invasive pulmonary aspergillosis","volume":"668","author":"Li","year":"2025","journal-title":"Int. J. Pharm."},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Lanser, D.M., Turner, A., Pacifici, N., Vu, K., Lewis, J., and Gelli, A. (2026). Conjugation of a Cryptococcus neoformans-derived metalloprotease to antifungal-loaded PLGA nanoparticles treats neural cryptococcosis in an in vitro model. PLoS ONE, 21.","DOI":"10.1371\/journal.pone.0340202"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"e19199","DOI":"10.7717\/peerj.19199","article-title":"Nanoparticle-based antifungal therapies innovations mechanisms and future prospects","volume":"13","author":"Wu","year":"2025","journal-title":"PeerJ"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s11051-025-06372-5","article-title":"Protein based nanoparticles for pulmonary drug delivery: Advances, challenges, and future perspectives","volume":"27","author":"Bhardwaj","year":"2025","journal-title":"J. Nanopart Res."},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"de Rezende, C.P., Santos, P.W.S., Piraine, R.A., Silvestrini, V.C., Barbosa, J.C.J., Valera, F.C.P., Tamashiro, E., Podolski-Gondim, G.G., Quintana, S.M., and Rodrigo Calado, R. (2024). Extracellular vesicles produced during fungal infection in humans are immunologically active. bioRxiv.","DOI":"10.1101\/2024.03.20.585987"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.procbio.2023.02.028","article-title":"Extracellular vesicles in vaccine development and therapeutic approaches for viral diseases","volume":"128","author":"Pordanjani","year":"2023","journal-title":"Process Biochem."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"e00045-25","DOI":"10.1128\/aac.00045-25","article-title":"Vesicle inhibition reduces Candida biofilm resistance","volume":"69","author":"Kim","year":"2025","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"122699","DOI":"10.1016\/j.lfs.2024.122699","article-title":"Geldanamycin confers fungicidal properties to azole by triggering the activation of succinate dehydrogenase","volume":"348","author":"Xiong","year":"2024","journal-title":"Life Sci."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"107041","DOI":"10.1016\/j.ejps.2025.107041","article-title":"Extracellular fungal Hsp90 represents a promising therapeutic target for combating fungal infections","volume":"207","author":"Fang","year":"2025","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Rouges, C., Asad, M., Laurent, A.D., Marchand, P., and Le Pape, P. (2023). Is the C-Terminal Domain an Effective and Selective Target for the Design of Hsp90 Inhibitors against Candida Yeast?. Microorganisms, 11.","DOI":"10.3390\/microorganisms11122837"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"e02529-18","DOI":"10.1128\/mBio.02529-18","article-title":"Genetic Analysis of Candida auris Implicates Hsp90 in Morphogenesis and Azole Tolerance and Cdr1 in Azole Resistance","volume":"10","author":"Kim","year":"2019","journal-title":"mBio"},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Lee, M., Lee, M., Song, Y., Kim, S., and Park, N. (2024). Recent Advances and Prospects of Nucleic Acid Therapeutics for Anti-Cancer Therapy. Molecules, 29.","DOI":"10.3390\/molecules29194737"},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Chen, F., Liu, Q., Xiong, Y., and Xu, L. (2022). Nucleic acid strategies for infectious disease treatments: The nanoparticle-based oral delivery route. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.984981"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"uqag008","DOI":"10.1093\/femsml\/uqag008","article-title":"Advances in molecular tools for elucidating nucleic acid biology in fungal pathogens","volume":"7","author":"Schrettenbrunner","year":"2026","journal-title":"microLife"},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Mundhe, A.K., and Rajkumari, R. (2025). Overcoming antifungal resistance in Candida albicans via RNA interference: A therapeutic perspective. Front. Cell. Infect. Microbiol., 15.","DOI":"10.3389\/fcimb.2025.1675921"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41541-025-01079-z","article-title":"Developing mRNA lipid nanoparticle vaccine effective for cryptococcosis in a murine model","volume":"10","author":"Li","year":"2025","journal-title":"npj Vaccines"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.tim.2021.09.007","article-title":"RNA-based therapeutics to treat human fungal infections","volume":"30","author":"Bruch","year":"2022","journal-title":"Trends Microbiol."},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Liu, H., Wang, C., Huang, W., Hu, S., and Huang, C. (2026). Immune evasion, dysregulation, and emerging immunotherapies for invasive fungal infections in the immunocompromised host. Front. Immunol., 17.","DOI":"10.3389\/fimmu.2026.1788786"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"100472","DOI":"10.1016\/j.lddd.2026.100472","article-title":"QSAR-based virtual screening of drugbank entries to identify potent lanosterol 14\u03b1-demethylase inhibitors","volume":"23","author":"Kaushik","year":"2026","journal-title":"Lett. Drug Des. Discov."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"5031577","DOI":"10.1155\/2022\/5031577","article-title":"Fluconazole-Like Compounds as Potential Antifungal Agents: QSAR, Molecular Docking, and Molecular Dynamics Simulation","volume":"2022","author":"Salehi","year":"2022","journal-title":"J. Chem."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1007\/s11030-025-11404-2","article-title":"Interpretable Quantitative Structure-Activity Relationship (QSAR) for identification of potent antifungal activity agents towards Candida albicans ATCC 2091","volume":"30","author":"Zapadka","year":"2026","journal-title":"Mol. Divers."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1021\/acspolymersau.5c00057","article-title":"Machine Learning-Guided Design of High-Performance Antifungal Polymers against Candida albicans","volume":"5","author":"Roh","year":"2025","journal-title":"ACS Polym. Au"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1080\/17460913.2025.2525717","article-title":"Employing machine learning for identifying antifungal compounds against Candida albicans","volume":"20","author":"Silva","year":"2025","journal-title":"Future Microbiol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"25150","DOI":"10.1038\/s41598-026-53519-y","article-title":"Early antifungal resistance prediction based on MALDI-TOF mass spectrometry and machine learning","volume":"16","author":"Duroux","year":"2026","journal-title":"Sci. Rep."},{"key":"ref_144","doi-asserted-by":"crossref","unstructured":"Berman, D.S., Lewis, L.M., Curtis, T.D., Tiburzi, O.N., Smith, D.F.Q., and Casadevall, A. (2026). Fung-AI: An AI\/ML-driven pipeline for antifungal peptide discovery. PLoS Comput. Biol., 22.","DOI":"10.64898\/2026.03.09.710548"},{"key":"ref_145","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Yang, X.R., Wang, S., Su, J.Q., and Zhu, Y.G. (2026). Population genomics reveals environmental reservoirs and antifungal resistance mechanisms in major non-albicans Candida species. J. Environ. Sci., 105572.","DOI":"10.1016\/j.jes.2026.105572"},{"key":"ref_146","unstructured":"(2026, August 05). Available online: https:\/\/www.ema.europa.eu\/en\/human-regulatory-overview\/research-development\/quality-design."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"126514","DOI":"10.1016\/j.ijpharm.2025.126514","article-title":"Quality-by-design-steered development of luliconazole-loaded ultra-deformable ethosomes for topical delivery: Improved dermatokinetics and antifungal activity","volume":"690","author":"Mahajan","year":"2025","journal-title":"Int. J. Pharm."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"20","DOI":"10.18579\/jopcr\/v18.1.roopesh","article-title":"Development of a Novel Emulsified Oral Dosage form of an Antifungal Drug in a Quality by Design Framework and Verifying its Critical Quality Attributes","volume":"18","author":"Roopesh","year":"2019","journal-title":"J. Pharm. Res."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s12247-025-10075-8","article-title":"Development of Sertaconazole Loaded Nanoemulgel Using Quality by Design Approach for Enhanced Antifungal Drug Delivery","volume":"20","author":"Pandey","year":"2025","journal-title":"J. Pharm. Innov."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"636","DOI":"10.5530\/jyp.20250014","article-title":"Quality by Design-Driven Formulation and Evaluation of an Itraconazole Film-Forming Gel for Enhanced Antifungal Activity","volume":"17","author":"Somwanshi","year":"2025","journal-title":"J. Young Pharm."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1208\/s12248-025-01079-w","article-title":"Rethinking Pharmaceutical Industry with Quality by Design: Application in Research, Development, Manufacturing, and Quality Assurance","volume":"27","author":"Duarte","year":"2025","journal-title":"AAPS J."},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"In\u00e1cio, M.M., Moreira, A.L.E., Cruz-Leite, V.R.M., Mattos, K., Silva, L.O.S., Venturini, J., Ruiz, O.H., Ribeiro-Dias, F., Weber, S.S., and Soares, C.M.A. (2023). Fungal Vaccine Development: State of the Art and Perspectives Using Immunoinformatics. J. Fungi, 9.","DOI":"10.3390\/jof9060633"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"114091","DOI":"10.1016\/j.isci.2025.114091","article-title":"Advances in fungal vaccine development: Progress in the face of emerging challenges","volume":"12","author":"Moses","year":"2025","journal-title":"iScience"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"e13238","DOI":"10.1111\/cmi.13238","article-title":"Protective effect of fungal extracellular vesicles against murine candidiasis","volume":"22","author":"Vargas","year":"2020","journal-title":"Cell. Microbiol."}],"container-title":["Journal of Fungi"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2309-608X\/12\/9\/659\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T08:18:16Z","timestamp":1788337096000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2309-608X\/12\/9\/659"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,2]]},"references-count":154,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["jof12090659"],"URL":"https:\/\/doi.org\/10.3390\/jof12090659","relation":{},"ISSN":["2309-608X"],"issn-type":[{"value":"2309-608X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,2]]}}}